PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 31 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $7,000 | -30.0% | 5,769 | -32.1% | 0.01% | -12.5% |
Q1 2017 | $10,000 | -52.4% | 8,501 | -41.7% | 0.01% | -11.1% |
Q4 2016 | $21,000 | +2000.0% | 14,585 | +1911.7% | 0.01% | +800.0% |
Q3 2016 | $1,000 | -90.0% | 725 | -90.0% | 0.00% | -85.7% |
Q2 2016 | $10,000 | – | 7,225 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Verity Asset Management, Inc. | 85,378 | $301,000 | 0.33% |
Tower Research Capital LLC (TRC) | 54,690 | $193,000 | 0.03% |
Psagot Value Holdings Ltd. | 54,348 | $191,000 | 0.01% |
OPPENHEIMER & CO INC | 36,450 | $128,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 2,900 | $10,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 34,571 | $121,000 | 0.00% |
Commonwealth Equity Services, Inc | 11,100 | $39,000 | 0.00% |
GROUP ONE TRADING, L.P. | 18,844 | $66,000 | 0.00% |
CITIGROUP INC | 737 | $3,000 | 0.00% |
VAN ECK ASSOCIATES CORP | 21,179 | $75,000 | 0.00% |